{
    "2020-01-07": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Dow Jones Today: Middle East Focus Factors Into The Equation Again",
                "features": {
                    "keywords": [
                        "Dow",
                        "Jones",
                        "Middle East",
                        "Focus",
                        "Factors"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance",
                        "global markets"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Ignore the Analysts: Johnson & Johnson Faces Serious Legal Liability",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Legal Liability",
                        "Analysts"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "JNJ Stock Is Technically Inside A Buy Zone â€” Is It Time To Buy Shares?",
                "features": {
                    "keywords": [
                        "JNJ",
                        "Stock",
                        "Buy Zone",
                        "Buy Shares"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Protagonist (PTGX) Starts Study on PTG-300 for Blood Disorder",
                "features": {
                    "keywords": [
                        "Protagonist",
                        "PTGX",
                        "Study",
                        "PTG-300",
                        "Blood Disorder"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}